Sunshine Biopharma Inc. Share Price
SBFMSunshine Biopharma Inc. Stock Performance
Open $2.15 | Prev. Close $2.17 | Circuit Range N/A |
Day Range $2.15 - $2.15 | Year Range $0.25 - $3.01 | Volume 145 |
Average Traded $2.15 |
Sunshine Biopharma Inc. Share Price Chart
About Sunshine Biopharma Inc.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Sunshine Biopharma Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $2.15 | $2.15 | +0.00% |
10-Jun-26 | $2.15 | $2.15 | -0.46% |
09-Jun-26 | $2.31 | $2.17 | -9.03% |
08-Jun-26 | $2.41 | $2.38 | -4.61% |
05-Jun-26 | $2.48 | $2.50 | -2.54% |
04-Jun-26 | $2.54 | $2.56 | -4.48% |
03-Jun-26 | $2.42 | $2.68 | +2.68% |
FAQs on Sunshine Biopharma Inc. Share Price
Can I buy Sunshine Biopharma Inc. shares in India?
What is the share price of Sunshine Biopharma Inc.?
What is the 5 year returns of Sunshine Biopharma Inc.?
What are the high & low stock price of Sunshine Biopharma Inc. today?
What is the 52-week high and low of Sunshine Biopharma Inc. stock?